Search Browse Earnings

MetaVia Inc.

Nasdaq:MTVA

Pharmaceutical Preparations·CAMBRIDGE, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

MetaVia Inc. — SlamSEC

Revenue

—

Adj. EBITDA

-$15.9M

FY 2024

Net Income

-$12.5M

FY 2024

EPS (Diluted)

-$2.46

FY 2024

Stock Price

$1.56

-2.5%

2026-03-06

52W Range

$1.43 – $23.10

P/E Ratio

-0.6x

Market Cap

$37.8M

Cash

$22.4M

FY 2024

Total Debt

—

Net Cash

$22.4M

Enterprise Value

$15.3M

Debt / EBITDA

1.4x

FY 2024

EV / EBITDA

-1.0x

Employees

—

CEO

Kim Hyung Heon

CFO

Woodworth Marshall H